Multiple
Sclerosis (MS) Drugs
|
|
|
Betaseron
®
|
(interferon beta-1b)
|
| |
MS Drugs - Betaseron
®
Efficacy
|
(Effectiveness of Betaseron ®)
|
| |
How effective is Betaseron ®?
|
| |
|
% of patients exacerbation free
at end of 2 years
|
|
Placebo
|
Betaseron ® |
Betaseron ® |
|
0.05mg |
0.25mg |
|
| Note: Patients on the study who required more than
three 28-day courses of corticosteroids were removed from the study |
|
|
|
Number of exacerbations in Subset (people who completed
full 2 years) completing 2 years of Betaseron
|
| |
|
No. of Exacerbations
|
Placebo
|
Betaseron ®
|
Betaseron ®
|
|
0.05mg
|
0.25mg
|
|
0 |
20 % |
22 % |
29 % |
|
1 |
32 % |
31 % |
39 % |
|
2 |
20 % |
28 % |
17 % |
|
3 |
15 % |
15 % |
14 % |
|
4 |
15 % |
7 % |
9 % |
|
≥ 5 |
21 % |
16 % |
8 % |
|
| Ref: Betaseron ® prescribing information
|
|
|
| |
| Reviewed July 2004 |
| |
